查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年按类型（细胞分离、组织分离）、按产品（酶解离）、按最终用途、按地区、按细分市场划分的细胞解离市场规模、份额、趋势分析报告
市场调查报告书
商品编码
1233239

2023-2030 年按类型（细胞分离、组织分离）、按产品（酶解离）、按最终用途、按地区、按细分市场划分的细胞解离市场规模、份额、趋势分析报告

Cell Dissociation Market Size, Share & Trends Analysis Report By Type (Cell Detachment, Tissue Dissociation), By Product (Enzymatic Dissociation), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

细胞解离市场的增长和趋势

Grand View Research, Inc. 的一份新报告预测，到 2030 年，全球细胞解离市场规模将达到 8.633 亿美元，复合年增长率为总收入的 13.55%。预计。

慢性病和传染病患病率的上升以及对基于细胞的疗法的日益关注正在推动市场的增长。 此外，增加对基于细胞的研究的资助和增加自动化仪器的使用是推动该行业发展的主要因素。 随着越来越多地使用患者来源的细胞作为研究模型系统，对高质量细胞材料的需求也在不断发展。 从组织中提取单个细胞的能力目前是基于细胞的诊断技术的瓶颈，并且在组织工程、新型诊断、癌症研究和个性化医学方法领域仍然至关重要。

主要挑战是细胞质量和产量、纯度和完整性、重现性和通量。 为了克服这些限制，Institut fur Politikwissenschaft 的研究人员正在开发一种机械组织分解系统，该系统基于集成到标准 50 毫升离心管中的反向旋转磨牙。 COVID-19 大流行对市场增长产生了积极影响。 细胞解离和组织解离主要用于支持间充质基质细胞 (MSC) 的细胞疗法。 因此，COVID-19 流行病增加了这些酶的使用，推动了市场增长。 近年来，干细胞治疗已成为前沿和有前途的科研课题。

治疗学的发展提供了巨大的机遇。 干细胞具有成为医学最重要方面之一的巨大潜力。 干细胞不仅会在恢復性疗法的开发中发挥重要作用，它们的研究还将揭示有关人类发育过程中发生的复杂事件的新信息。 此外，不仅细胞培养广泛用于研究干细胞生物学的基础研究，而且培养的干细胞的治疗应用也被期待，因此人们对改进干细胞培养的兴趣越来越大。 解离在各种研究和治疗应用中起着重要作用，例如药物发现、开发和细胞治疗。

此外，增加临床试验、FDA 批准以及主要参与者合作等战略举措正在推动行业发展。 例如，2021年10月，总部位于德国专注于创新干细胞疗法临床开发的生物製药公司RHEACELL，其细胞治疗产品AMESANAR获得了德国药品法规定的国内批准。 2023年2月， IASO Biotherapeutics 获得美国食品药品监督管理局（USFDA）授予的用于治疗復发/难治性多发性骨髓瘤的 IND BCMA CAR-T CT103A 的先进再生医学指定和快速通道指定。 对原材料的严格监管和与动物源性产品相关的伦理问题可能会在一定程度上阻碍行业发展。

製造细胞疗法产品的指南仍在製定中。 然而，相关文件是USP 1046，其中规定了製造过程中使用的原材料的资格。 因此，考虑成分一致性、来源、杂质风险以及成分是否根据 GMP 指南生产等问题对批准有影响。 然而，在预测期内，对非动物源性 GMP 级酶的兴趣日益增长，预计将推动行业增长。 由于慢性病发病率高、政府对细胞治疗的资助增加以及实验室和临床研究的质量基础设施的存在，北美在 2022 年主导了全球产业。

细胞解离市场报告要点

  • 由于酶解产品在製药和生物技术公司中的需求和重要性不断增加，酶解产品部分将在 2022 年占据最高份额，从而导致该部分的加速采用和增长预计会增加。
  • 由于研发活动的增加和慢性病的高患病率，组织解离类型在 2022 年占了最大的收入份额。
  • 生物製药和製药公司的最终用户部门将在 2022 年引领行业发展，这得益于细胞疗法临床试验的增加、FDA 的批准以及对细胞和基因疗法的研究。
  • 亚太地区有望在预测期内实现最快的增长率。
  • 这是由于对新疗法的需求不断增长以及基础设施的快速发展。

内容

第一章研究方法论

  • 市场细分和范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法逐个国家/地区进行市场估算
  • 全球市场：CAGR 计算
  • 调查假设
  • 二级信息列表
  • 主要信息列表
  • 目的
  • 缩写列表

第二章市场定义

第 3 章执行摘要

  • 市场概览

第 4 章全球细胞解离市场变量、趋势和范围

  • 细胞解离市场谱系展望
    • 母公司市场展望
  • 描绘渗透率和增长前景
  • 市场驱动因素分析
    • 对开发基于细胞的疗法的兴趣与日俱增
    • 增加对细胞研究的资助
    • 细胞解离装置技术进展
  • 市场製约因素分析
    • 严格的规定
  • 市场机会分析
    • 越来越关注干细胞研究
  • 波特的五力分析
  • 细胞解离市场：COVID-19 影响分析

第 5 章细胞解离市场 - 细分分析，副产品，2018-2030（百万美元）

  • 全球细胞解离市场：产品差异分析
  • 酶解
    • 胰蛋白酶
    • 胶原酶
    • 弹性蛋白酶
    • 木瓜蛋白酶
    • 透明质酸酶
    • DNase
    • 其他
  • 非酶解
  • 设备和配件

第 6 章细胞解离市场 - 细分分析，按类型，2018-2030（百万美元）

  • 全球细胞解离市场：类型变异分析
  • 组织解离
  • 细胞分离

第 7 章细胞解离市场 - 细分分析，按最终用途，2018-2030（百万美元）

  • 细胞解离市场：最终用户差异分析
  • 製药和生物技术公司
  • 研究和学术机构

第 8 章细胞解离市场：-按地区划分的细分分析，2018-2030 年（百万美元）

  • 细胞解离市场：区域差异分析
  • 北美
    • SWOT 分析
    • 美国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 加拿大
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
  • 欧洲
    • SWOT 分析
    • 德国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 英国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 法国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 意大利
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 西班牙
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 丹麦
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 瑞典
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 挪威
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
  • 亚太地区
    • SWOT 分析
    • 日本
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 中国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 印度
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 韩国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 澳大利亚
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 泰国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
  • 拉丁美洲
    • SWOT 分析
    • 巴西
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 墨西哥
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 阿根廷
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
  • 多边环境协定
    • SWOT 分析
    • 南非
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 沙特阿拉伯
      • 主要国家动态
      • 目标疾病的患病率
      • 衝突设想
      • 监管框架
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架
    • 科威特
      • 主要国家动态
      • 目标疾病的患病率
      • 竞争场景
      • 监管框架

第9章竞争格局

  • 公司分类
  • 公司市场定位
  • 2022 年公司市场份额分析
  • 公司热图分析
  • 战略规划
  • 公司简介/列表
    • Thermo Fisher Scientific Inc.
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • Danaher Corporation
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • STEMCELL Technologies
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • Merck KGaA
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • BD
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • Sartorius AG
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • Miltenyi Biotec
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • PAN-Biotech
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • HiMedia Laboratories
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • F. Hoffmann-La Roche Ltd
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
    • S2 Genomics, Inc.
      • 概览
      • 财务业绩（净收入/销售额/EBITDA/毛利）
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-037-4

Cell Dissociation Market Growth & Trends:

The global cell dissociation market size is expected to reach USD 863.3 million by 2030, registering a CAGR of 13.55% of the overall revenue, according to a new report by Grand View Research, Inc. The rising prevalence of chronic and infectious diseases, coupled with the increasing focus on cell-based therapeutics, is boosting market growth. In addition, growing funding for cell-based research and increasing use of automated instruments are the key factors driving the industry. With the growing applications of patient-derived cells as a model system for research, the necessity for high-quality cell material is constantly developing. The capability to extract individual cells from tissues is presently a bottleneck for cell-based diagnostic technologies and remains vital in the areas of tissue engineering, emerging diagnostic methods, cancer research, and personalized medicine approaches.

Key challenges comprise the quality and yield or the purity and integrity of cells as well as reproducibility and throughput. To overcome these limitations, researchers from Institut fur Politikwissenschaft are developing a mechanical tissue dissociation system based on counter-rotating rows of grinding teeth integrated into a standard 50 ml centrifuge tube. The COVID-19 pandemic influenced market growth positively. Cell dissociation and tissue dissociation are used to aid cell-based therapies, primarily using Mesenchymal Stromal Cells (MSCs). As a result, the usage of these enzymes increased due to the COVID-19 pandemic, which augmented market growth. In current years, stem cell therapy has become an advanced and promising scientific research topic.

The development of treatment methods has induced great opportunities. Stem cells have considerable potential to become one of the most significant aspects of medicine. In addition to the fact that they play a huge role in developing restorative therapy, their study also divulges additional information about the complex events that happen during human development. Moreover, there is a growing interest in improving stem cell culture, not only because cell culture is extensively used in basic research for studying stem cell biology but also due to the potential therapeutic applications of cultured stem cells. Dissociation plays an important role in various research and therapeutic applications, including drug discovery, development, and cell therapy.

Furthermore, increasing clinical trials, FDA approvals, and strategic initiatives, such as collaborations by major players, are boosting industry growth. For instance, in October 2021, RHEACELL, a biopharmaceutical company headquartered in Germany, focused on the clinical development of innovative stem cell therapeutics, received national approval under the German Medicinal Products Act for its cell therapy product AMESANAR. In February 2023, IASO Biotherapeutics received Regenerative Medicine Advanced Therapy designation and Fast Track designation from USFDA for its IND BCMA CAR-T CT103A for relapsed/refractory multiple myeloma. Stringent regulations for raw materials and ethical issues concerning animal-derived products might hamper the industry's growth to a certain extent.

The guidelines for the manufacturing of cell therapy products are still progressing. Still, the relevant reference is the USP 1046, which designates the significance of qualifying raw materials used in the manufacturing process. Thus, considering the concerns, such as raw material consistency, origin, risk of impurity, and whether the raw material was manufactured under the GMP guidelines, is significant for approval. However, there is a growing interest in Animal-origin free and GMP-grade enzymes, which will drive the industry growth during the forecast period. North America dominated the global industry in 2022 due to the high incidence of chronic diseases, the rise in investment funding by the government for cell therapy, and the presence of high-quality infrastructure for laboratory and clinical research.

Cell Dissociation Market Report Highlights:

  • The enzymatic dissociation product segment accounted for the highest share in 2022 due to increased requirements and the importance of enzymatic dissociation products for pharmaceutical & biotechnology companies, which, in turn, is likely to boost the adoption and anticipate the segment growth
  • The tissue dissociation type segment held the largest revenue share in 2022 owing to the increased R&D activities and high prevalence of chronic disorders
  • The biopharmaceutical & pharmaceutical companies end-user segment led the industry in 2022 owing to growth in clinical trials of cell-based therapeutics, FDA approvals, and research on cell & gene therapy
  • The Asia Pacific region is expected to register the fastest growth rate during the forecast period
  • This is owing to the rising demand for novel therapeutics and rapid infrastructural development

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Cell Dissociation Market Variables, Trends, & Scope

  • 4.1 Cell Dissociation Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration And Growth Prospect Mapping
  • 4.3 Market Driver Analysis
    • 4.3.1 Rising Focus On The Development Of Cell-Based Therapeutics
    • 4.3.2 Growing Funding For Cell-Based Research
    • 4.3.3 Technological Advancements In Cell Dissociations Instruments
  • 4.4 Market Restraint Analysis
    • 4.4.1 Stringent Regulations
  • 4.5 Market Opportunity Analysis
    • 4.5.1 Growing Emphasis On Stem Cell Research
  • 4.6 Porter's Five Forces Analysis
  • 4.7 Cell Dissociation Market: COVID-19 Impact Analysis

Chapter 5 Cell Dissociation Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 5.1 Global Cell Dissociation Market: Product Movement Analysis
  • 5.2 Enzymatic Dissociation
    • 5.2.1 Enzymatic Dissociation market estimates and forecast, 2018-2030, USD million
    • 5.2.2 Trypsin
      • 5.2.2.1 Trypsin market estimates and forecast, 2018-2030, USD million
    • 5.2.3 Collagenase
      • 5.2.3.1 Collagenase market estimates and forecast, 2018-2030, USD million
    • 5.2.4 Elastase
      • 5.2.4.1 Elastase market estimates and forecast, 2018-2030, USD million
    • 5.2.5 Papain
      • 5.2.5.1 Papain market estimates and forecast, 2018-2030, USD million
    • 5.2.6 Hyaluronidase
      • 5.2.6.1 Hyaluronidase market estimates and forecast, 2018-2030, USD million
    • 5.2.7 DNase
      • 5.2.7.1 DNase market estimates and forecast, 2018-2030, USD million
    • 5.2.8 Others
      • 5.2.8.1 Others market estimates and forecast, 2018-2030, USD million
  • 5.3 Non-Enzymatic Dissociation
    • 5.3.1 Non-Enzymatic dissociation market estimates and forecast, 2018-2030, USD million
  • 5.4 Instruments & Accessories
    • 5.4.1 Instruments & accessories market estimates and forecast, 2018-2030, USD million

Chapter 6 Cell Dissociation Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 6.1 Global Cell Dissociation Market: Type Movement Analysis
  • 6.2 Tissue Dissociation
    • 6.2.1 Tissue dissociation market estimates and forecast, 2018-2030, USD million
  • 6.3 Cell Detachment
    • 6.3.1 Cell detachment market estimates and forecast, 2018-2030, USD million

Chapter 7 Cell Dissociation Market- Segment Analysis, by End-user, 2018 - 2030 (USD Million)

  • 7.1 Cell Dissociation Market: End-user Movement Analysis
  • 7.2 Pharmaceutical And Biotechnology Companies
    • 7.2.1 Pharmaceutical And Biotechnology Companies market estimates and forecast, 2018-2030, USD million
  • 7.3. Research & Academic Institutes
    • 7.3.1 Research & academic institutes market estimates and forecast, 2018-2030, USD million

Chapter 8 Cell Dissociation Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Cell Dissociation Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 SWOT analysis
      • 8.2.1.1 North America cell dissociation market, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key country dynamics
      • 8.2.2.2 Target disease prevalence
      • 8.2.2.3 Competitive scenario
      • 8.2.2.4 Regulatory framework
      • 8.2.2.5 U.S. cell dissociation market, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Key country dynamics
      • 8.2.3.2 Target disease prevalence
      • 8.2.3.3 Competitive scenario
      • 8.2.3.4 Regulatory framework
      • 8.2.3.5 Canada cell dissociation market, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 SWOT Analysis
      • 8.3.1.1 Europe cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Key country dynamics
      • 8.3.2.2 Target disease prevalence
      • 8.3.2.3 Competitive scenario
      • 8.3.2.4 Regulatory framework
      • 8.3.2.5 Germany cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 Key country dynamics
      • 8.3.3.2 Target disease prevalence
      • 8.3.3.3 Competitive scenario
      • 8.3.3.4 Regulatory framework
      • 8.3.3.5 U.K. cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 Key country dynamics
      • 8.3.4.2 Target disease prevalence
      • 8.3.4.3 Competitive scenario
      • 8.3.4.4 Regulatory framework
      • 8.3.4.5 France cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Key country dynamics
      • 8.3.5.2 Target disease prevalence
      • 8.3.5.3 Competitive scenario
      • 8.3.5.4 Regulatory framework
      • 8.3.5.5 Italy cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Key country dynamics
      • 8.3.6.2 Target disease prevalence
      • 8.3.6.3 Competitive scenario
      • 8.3.6.4 Regulatory framework
      • 8.3.6.5 Spain cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.7 Denmark
      • 8.3.7.1 Key country dynamics
      • 8.3.7.2 Target disease prevalence
      • 8.3.7.3 Competitive scenario
      • 8.3.7.4 Regulatory framework
      • 8.3.7.5 Denmark cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.8 Sweden
      • 8.3.8.1 Key country dynamics
      • 8.3.8.2 Target disease prevalence
      • 8.3.8.3 Competitive scenario
      • 8.3.8.4 Regulatory framework
      • 8.3.8.5 Sweden cell dissociation market, 2018 - 2030 (USD Million)
    • 8.3.9 Norway
      • 8.3.9.1 Key country dynamics
      • 8.3.9.2 Target disease prevalence
      • 8.3.9.3 Competitive scenario
      • 8.3.9.4 Regulatory framework
      • 8.3.9.5 Norway cell dissociation market, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 SWOT Analysis
      • 8.4.1.1 Asia Pacific cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key country dynamics
      • 8.4.2.2 Target disease prevalence
      • 8.4.2.3 Competitive scenario
      • 8.4.2.4 Regulatory framework
      • 8.4.2.5 Japan cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 Key country dynamics
      • 8.4.3.2 Target disease prevalence
      • 8.4.3.3 Competitive scenario
      • 8.4.3.4 Regulatory framework
      • 8.4.3.5 China cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 Key country dynamics
      • 8.4.4.2 Target disease prevalence
      • 8.4.4.3 Competitive scenario
      • 8.4.4.4 Regulatory framework
      • 8.4.4.5 India cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 Key country dynamics
      • 8.4.5.2 Target disease prevalence
      • 8.4.5.3 Competitive scenario
      • 8.4.5.4 Regulatory framework
      • 8.4.5.5 South Korea cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.3.9.1 Key country dynamics
      • 8.4.6.2 Target disease prevalence
      • 8.4.6.3 Competitive scenario
      • 8.4.6.4 Regulatory framework
      • 8.4.6.5 Australia cell dissociation market, 2018 - 2030 (USD Million)
    • 8.4.7 Thailand
      • 8.4.7.1 Key country dynamics
      • 8.4.7.2 Target disease prevalence
      • 8.4.7.3 Competitive scenario
      • 8.4.7.4 Regulatory framework
      • 8.4.7.5 Thailand cell dissociation market, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 SWOT Analysis
      • 8.5.1.1 Latin America cell dissociation market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key country dynamics
      • 8.5.2.2 Target disease prevalence
      • 8.5.2.3 Competitive scenario
      • 8.5.2.4 Regulatory framework
      • 8.5.2.5 Brazil cell dissociation market, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Key country dynamics
      • 8.5.3.2 Target disease prevalence
      • 8.5.3.3 Competitive scenario
      • 8.5.3.4 Regulatory framework
      • 8.5.3.5 Mexico cell dissociation market, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Key country dynamics
      • 8.5.4.2 Target disease prevalence
      • 8.5.4.3 Competitive scenario
      • 8.5.4.4 Regulatory framework
      • 8.5.4.5 Argentina cell dissociation market, 2018 - 2030 (USD Million)
  • 8.6 MEA
    • 8.6.1 SWOT Analysis
      • 8.6.1.1 MEA cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.4.1 Key country dynamics
      • 8.6.2.2 Target disease prevalence
      • 8.6.2.3 Competitive scenario
      • 8.6.2.4 Regulatory framework
      • 8.6.2.5 South Africa cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key country dynamics
      • 8.6.3.2 Target disease prevalence
      • 8.6.3.3 Competitive scenario
      • 8.6.3.4 Regulatory framework
      • 8.6.3.5 Saudi Arabia cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 Key country dynamics
      • 8.6.4.2 Target disease prevalence
      • 8.6.4.3 Competitive scenario
      • 8.6.4.4 Regulatory framework
      • 8.6.4.5 UAE cell dissociation market, 2018 - 2030 (USD Million)
    • 8.6.5 Kuwait
      • 8.6.5.1 Key country dynamics
      • 8.6.5.2 Target disease prevalence
      • 8.6.5.3 Competitive scenario
      • 8.6.5.4 Regulatory framework
      • 8.6.5.5 Kuwait cell dissociation market, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Company Market Positioning
  • 9.3 Company Market Share Analysis, 2022
  • 9.4 Company Heat Map Analysis
  • 9.5 Strategy Mapping
  • 9.6 Company Profiles/Listing
    • 9.6.1 Thermo Fisher Scientific Inc.
      • 9.6.1.1. Overview
      • 9.6.1.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.1.3. Product benchmarking
      • 9.6.1.4. Strategic initiatives
    • 9.6.2 Danaher Corporation
      • 9.6.2.1. Overview
      • 9.6.2.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.2.3. Product benchmarking
      • 9.6.2.4. Strategic initiatives
    • 9.6.3 STEMCELL Technologies
      • 9.6.3.1. Overview
      • 9.6.3.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.3.3. Product benchmarking
      • 9.6.3.4. Strategic initiatives
    • 9.6.4 Merck KGaA
      • 9.6.4.1. Overview
      • 9.6.4.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.4.3. Product benchmarking
      • 9.6.4.4. Strategic initiatives
    • 9.6.5 BD
      • 9.6.5.1. Overview
      • 9.6.5.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.5.3. Product benchmarking
      • 9.6.5.4. Strategic initiatives
    • 9.6.6 Sartorius AG
      • 9.6.6.1. Overview
      • 9.6.6.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.6.3. Product benchmarking
      • 9.6.6.4. Strategic initiatives
    • 9.6.7 Miltenyi Biotec
      • 9.6.7.1. Overview
      • 9.6.7.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.7.3. Product benchmarking
      • 9.6.7.4. Strategic initiatives
    • 9.6.8 PAN-Biotech
      • 9.6.8.1. Overview
      • 9.6.8.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.8.3. Product benchmarking
      • 9.6.8.4. Strategic initiatives
    • 9.6.9 HiMedia Laboratories
      • 9.6.9.1. Overview
      • 9.6.9.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.9.3. Product benchmarking
      • 9.6.9.4. Strategic initiatives
    • 9.6.10 F. Hoffmann-La Roche Ltd
      • 9.6.10.1. Overview
      • 9.6.10.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.10.3. Product benchmarking
      • 9.6.10.4. Strategic initiatives
    • 9.6.11 S2 Genomics, Inc.
      • 9.6.11.1. Overview
      • 9.6.11.2. Financial performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.6.11.3. Product benchmarking
      • 9.6.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 4. Global cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 6. Global cell dissociation market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 9. North America cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 10. North America cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 11. U.S. Cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 12. U.S. Cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 14. Canada cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 15. Canada cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 16. Canada cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 17. Europe cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 18. Europe cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 19. Europe cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 20. Europe cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 21. U.K. cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 22. U.K. cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 23. U.K. cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 24. Germany cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 25. Germany cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 26. Germany cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 27. France cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 28. France cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 29. France cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 30. Italy cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 31. Italy cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 32. Italy cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 33. Spain cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 34. Spain cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 35. Spain cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 36. Denmark cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 37. Denmark cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 38. Denmark cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 39. Sweden cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 40. Sweden cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 41. Sweden cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 42. Norway cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 43. Norway cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 44. Norway cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 48. Asia pacific cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 49. China cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 50. China cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 51. China cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 52. India cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 53. India cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 54. India cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 55. Japan cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 56. Japan cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 57. Japan cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 58. Thailand cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 59. Thailand cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 60. Thailand cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 61. Australia cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 62. Australia cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 63. Australia cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 64. South Korea cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 65. South Korea cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 66. South Korea cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 67. Latin America cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 68. Latin America cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 69. Latin America cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 70. Latin America cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 71. Brazil cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 72. Brazil cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 73. Brazil cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 74. Mexico cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 75. Mexico cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 76. Mexico cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 77. Argentina cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 78. Argentina cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 79. Argentina cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa cell dissociation market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 84. South Africa cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 85. South Africa cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 86. South Africa cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 90. UAE cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 91. UAE cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 92. UAE cell dissociation market, end-user, 2018 - 2030 (USD Million)
  • Table 93. Kuwait cell dissociation market, by product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait cell dissociation market, by type, 2018 - 2030 (USD Million)
  • Table 95. Kuwait cell dissociation market, end-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell dissociation, market segmentation
  • Fig. 8 Market snapshot, 2021
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market penetration vs growth prospect mapping, 2021
  • Fig. 16 Global cell dissociation market: product movement analysis
  • Fig. 17 Global cell dissociation market, for enzymatic dissociation, 2018 - 2030 (USD Million)
  • Fig. 18 Global cell dissociation market, for trypsin, 2018 - 2030 (USD Million)
  • Fig. 19 Global cell dissociation market, for collagenase, 2018 - 2030 (USD Million)
  • Fig. 20 Global cell dissociation market, for elastase, 2018 - 2030 (USD Million)
  • Fig. 21 Global cell dissociation market, for papain, 2018 - 2030 (USD Million)
  • Fig. 22 Global cell dissociation market, for hyaluronidase, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell dissociation market, for DNase, 2018 - 2030 (USD Million)
  • Fig. 24 Global cell dissociation market, for others, 2018 - 2030 (USD Million)
  • Fig. 25 Global cell dissociation market, for non-enzymatic dissociation, 2018 - 2030 (USD Million)
  • Fig. 26 Global cell dissociation market, for instruments & accessories, 2018 - 2030 (USD Million)
  • Fig. 27 Global cell dissociation market: type movement analysis
  • Fig. 28 Global cell dissociation market, for tissue dissociation, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell dissociation market, for cell detachment, 2018 - 2030 (USD Million)
  • Fig. 30 Global cell dissociation market: end-user movement analysis
  • Fig. 31 Global cell dissociation market, for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 32 Global cell dissociation market, for research and academics institutes, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace: key takeaways
  • Fig. 34 Regional outlook, 2022 & 2030
  • Fig. 35 Global flow cytometry market: region movement analysis
  • Fig. 36 North America cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 42 France cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia pacific cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 49 China cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 50 India cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE cell dissociation market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait cell dissociation market, 2018 - 2030 (USD Million)